Diamonds and Dogs

9/8/22

Regeneron Pharma (REGN) jumps on positive drug trial news. Regeneron is up 14% as their anti-blindness treatment Eylea, was shown to work as well when given at a higher dose at a longer interval between injections. Eylea, which is normally given at 2 milligrams every eight weeks, was shown in two late-stage trials to be as effective when given at 8 mg at longer intervals, without any additional safety issues.

American Eagle (AEO) lower following earnings. The once popular teen retailer is down 10% after missing second quarter estimates. The company blames slowdown on consumer spending and bloated inventory. The company is stepping up cost-cutting and pausing its dividend to give the firm more financial flexibility.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.